← Learning sections

2 films available · 6 in development

Repair, Recovery & Tissue Health

An eight-part collection following repair research from experiments to defined clinical applications. Start with BPC-157, then explore the original sources. The sequence organizes evidence questions, not treatment rankings.

Watch the collection

01 · Available · 2:12 · English

BPC-157: repair and digestive research

Tissue recovery, gastric research, and the distance between encouraging findings and established human benefit.

Watch the film, transcript & references →

02 · Available · 2:03 · English

Thymosin beta-4 & TB-500: identify the molecule

Molecular identity, corneal research, and matching a claim to the preparation actually tested.

Watch the film, transcript & references →

The remaining six topics

GHK-Cu is next in development. The links below open available research, not finished videos. Becaplermin and cenegermin are growth-factor proteins within the wider peptide/protein signaling landscape.

  1. 03 · Next · In development

    GHK-Cu

    How does a cellular finding become evidence of a clinical benefit?

    Explore available research →
  2. 04 · Planned

    Becaplermin / PDGF-BB

    What does a defined wound-closure result establish?

    Explore available research →
  3. 05 · Planned

    Cibinetide / ARA-290

    How do nerve-fiber measurements relate to symptoms and function?

    Explore available research →
  4. 06 · Planned

    Cenegermin / NGF

    How is a repair signal evaluated for a particular corneal disease?

    Explore available research →
  5. 07 · Planned

    Teriparatide / PTH(1–34)

    How do bone measurements differ from fracture outcomes?

    Explore available research →
  6. 08 · Planned

    Teduglutide / GLP-2

    What changes in intestinal function were actually measured?

    Explore available research →

Experimental research, an approved product in a defined setting, and a broad recovery claim provide different kinds of information. Each published film identifies the studied preparation, outcomes, limitations, and applicable regulatory context.